Essential Reads: Lithium and Breastfeeding (2024)
Because women with bipolar disorder are at high risk for relapse during the postpartum period, we typically recommend that women continue treatment with lithium throughout the postpartum period. While this intervention clearly decreases risk for postpartum psychiatric illness, the use of lithium while breastfeeding presents certain challenges. Â
A New Threat to Pregnancy: Xylazine
Xylazine, a veterinary sedative, has become an increasingly common adulterant in the illicit opioid supply, posing unique risks to pregnant individuals and their developing fetuses.
Does Prenatal Cannabis Exposure Affect Executive Function in Preschool-Aged Children?
Prenatal cannabis exposure was associated with deficits in executive function and aggressive behavior; however, there are other important exposures to consider in this study.
Clinical Update 2024: Gabapentin (Neurontin) and Pregnancy
In this study with over 4000 infants exposed to gabapentin, the information is reassuring. While we cannot rule out the possibility of a small increase in risk of cardiovascular malformations in gabapentin-exposed infants, gabapentin does not appear to be a major teratogen.Â
Improving Cognitive Function After Surgical Menopause: A Randomized Controlled Trial of Lisdexamfetamine
The psychostimulant lisdexamfetamine was well-tolerated and improved both subjective and objective measures of attention and working memory in women undergoing surgical menopause.
Ketamine and Pregnancy: Taking a Look at the Practices of Ketamine Clinics
With ketamine and esketamine increasingly used to treat depression, especially in women of reproductive age, this study reveals important gaps in care, including inconsistencies in pregnancy testing, informed consent, and contraception practices among ketamine clinics in the United States.Â